Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care

Summary by Hastings Tribune
PRINCETON, N.J.--(BUSINESS WIRE)--Feb 3, 2026-

2 Articles

pharmtech.compharmtech.com
Center

Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D

The companies’ “Change the Target. Change What’s Possible” targets the potential of Factor XIa inhibition in the development of treatments for thromboembolic disease.

Read Full Article
Hastings TribuneHastings Tribune
Center

Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care

PRINCETON, N.J.--(BUSINESS WIRE)--Feb 3, 2026-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Tuesday, February 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Princeton, New Jersey icon

Princeton, New Jersey

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal